ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,534Medicare Part D Prescriptions Filled, Including Refills

Rank: 487 out of 2888

$556K Total Retail Price of All Prescriptions

Rank: 711 out of 2888

445 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
75% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 445 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 9,033 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
LEVOTHYROXINE SODIUM 556 488 1 1
LISINOPRIL 381 324 2 3
METFORMIN HCL 349 299 3 8
AMLODIPINE BESYLATE 257 238 4 5
SIMVASTATIN 247 233 5 2
PRAVASTATIN SODIUM 246 218 6 12
OMEPRAZOLE 211 196 7 7
HYDROCODONE-ACETAMINOPHEN 204 177 S3 8 4
TRAMADOL HCL 198 156 9 16
FUROSEMIDE 196 162 10 6
AZITHROMYCIN 176 141 11 38
DIOVAN HCT 156 137 12 61
SERTRALINE HCL 153 115 13 27
METOPROLOL TARTRATE 150 133 14 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 147 131 15 28
DICLOFENAC POTASSIUM 147 133 15 291
NEXIUM 145 116 17 19
GABAPENTIN 143 133 18 13
DIOVAN 139 124 19 35
DONEPEZIL HCL 139 139 19 26
AMLODIPINE BESYLATE-BENAZEPRIL 134 123 21 67
ATENOLOL 127 124 22 25
ATORVASTATIN CALCIUM 116 109 23 9
AMITRIPTYLINE HCL 112 92 R 24 74
CIPROFLOXACIN HCL 107 79 25 47
CYCLOBENZAPRINE HCL 101 80 R 26 68
GLIPIZIDE ER 99 82 27 107
NAMENDA 99 88 27 34
ALENDRONATE SODIUM 92 92 29 23
GLYBURIDE-METFORMIN HCL 92 68 R 29 64
CLONIDINE HCL 91 83 31 39
METOPROLOL SUCCINATE 87 85 32 11
POTASSIUM CHLORIDE 82 61 33 14
SUCRALFATE 80 46 34 187
CLOPIDOGREL 79 64 35 30
WARFARIN SODIUM 78 42 36 22
HYDROCHLOROTHIAZIDE 78 70 36 15
TAMSULOSIN HCL 76 68 38 29
GLIMEPIRIDE 70 59 39 36
ATENOLOL-CHLORTHALIDONE 68 50 40 234
MECLIZINE HCL 67 64 41 122
ISOSORBIDE MONONITRATE ER 66 66 42 51
SINGULAIR 66 61 42 85
KLOR-CON M20 64 57 44 90
ENALAPRIL MALEATE 63 63 45 49
PLAVIX 62 53 46 40
MIRTAZAPINE 61 61 47 54
BUMETANIDE 61 53 47 203
ZOLPIDEM TARTRATE 59 55 49 17
AMOX TR-POTASSIUM CLAVULANATE 58 41 50 112
MEGESTROL ACETATE 56 56 R 51 140
KLOR-CON M10 56 54 51 118
PREDNISONE 56 49 51 42
GLIPIZIDE 56 46 51 50
NIFEDIPINE ER 55 49 55 76
DIVALPROEX SODIUM ER 53 35 56 185
PAROXETINE HCL 53 53 56 84
JANUVIA 50 45 58 48
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 9, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.